Literature DB >> 18572785

Sinonasal neuroendocrine carcinoma: a case report.

Dulani Mendis1, Nasser Malik.   

Abstract

Neuroendocrine carcinoma (NEC) is rare. We report a case of probable sinonasal NEC in a 73-year-old man who had presented with a history of right nasal obstruction, nasal discharge, and recurrent epistaxis. On examination, a red, friable, gelatinous, polypoid mass with a tendency to bleed was seen in the right nasal cavity. Computed tomography revealed that the lesion was confined to the right nasal cavity; coincidental or reactive opacification was seen in the adjacent sinuses. The final histologic evaluation of the excised biopsy specimens yielded a diagnosis of an invasive, poorly differentiated NEC, probably a large-cell variant, with the differential diagnosis lying at a point somewhere between poorly differentiated large-cell NEC and high-grade olfactory neuroblastoma. The patient underwent a right lateral rhinotomy and medial maxillectomy followed by adjuvant radiotherapy. At 20 months of follow-up, he exhibited no sign of recurrence.

Entities:  

Mesh:

Year:  2008        PMID: 18572785

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  3 in total

1.  Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome.

Authors:  Anna Likhacheva; David I Rosenthal; Ehab Hanna; Michael Kupferman; Franco Demonte; Adel K El-Naggar
Journal:  Head Neck Oncol       Date:  2011-07-27

2.  Nomograms Forecasting Long-Term Overall and Cancer Specific Survival of Patients With Head and Neck Neuroendocrine Carcinoma.

Authors:  Ouying Yan; Wenji Xie; Haibo Teng; Shengnan Fu; Yanzhu Chen; Feng Liu
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 6.244

3.  Large Cell Neuroendocrine Carcinoma in the Sinonasal Cavity with Large Intracranial Extension Treated with Endonasal Endoscopic and Transcranial Combined Surgery: A Case Report.

Authors:  Yurie Rai; Hiroshi Nishioka; Takayuki Hara
Journal:  NMC Case Rep J       Date:  2021-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.